A United States-based medical expert, Dr. Olatunji Alese, has identified Nigerian MedEnhanz as a good platform providing the necessary skills for medical professionals to be armed with information that allow them to curb the rising cancer trends in Nigeria and other developing countries.

 

MedEnhanz is an online medical information company based in Nigeria providing a web-based medical information and clinical reference tool for Nigerian medical professionals.

 

According to Alese, who is a medical oncologist and assistant professor at Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, the oncology section of MedEnhanz’s continuing professional development activity provide rich information and skills for practitioners.

 

“A cancer is an important global health issue. Although, the epidemiology and outcomes of different cancers vary worldwide, rising cancer trends constitute an alarming health care burden in both industrialized and emerging economies.

 

 

“Unfortunately, the vast majority of cancer cases are in developing countries; 70 per cent of all cancer burdens but with less than five per cent of healthcare expenditure towards the care of these patients. Furthermore, adolescent and young adult (AYA) cancers make up the fastest growing group of cancer patients.

 

“Malignancies that typically present in older people such as colon cancer frequently affect individuals in third and fourth decade of life in Nigeria. In addition, vaccine preventable malignancies such as cervical and liver cancers continue to unnecessarily contribute to significant morbidity and mortality.

 

“It is, therefore, imperative that medical practitioners (including those practicing in resource limited countries) employ every available resource to maximise the care of their cancer patients.”

 

TO this end, Alese noted that MedEnhanz is a highly effective healthcare information platform, designed to advance medical practice in Nigeria and other Sub-Saharan African countries.

 

“I truly admire the innovative work of the MedEnhanz team, and the enthusiasm with which they have pursued their mission. Their consumer health solutions are unprecedented and attest to the visionary strategy the team has employed.

 

“The excellent ability of MedEnhanz to reach and enlighten healthcare practitioners places the platform at the forefront of cancer prevention and control in Nigeria. Cancer is currently not receiving the intensity of attention that is necessary to address its huge socioeconomic burden, and its increasing threat to the Nigerian population.”

 

By: The Punch